XRF Scientific Acquires Bruker AXS SE’s CGA Business for $4M Upfront

Why It Matters

The purchase diversifies XRF’s product range beyond mining, opening higher‑margin industrial segments while leveraging its cash strength, but execution risk around the manufacturing shift will be closely watched by investors.

Key Takeaways

• Acquisition price: $4 million upfront, up to $1 million earnout
• Manufacturing moves from Germany to Perth, slated for Q3 2026
• Revenue from CGA line expected to start in Q4 2026
• Deal values CGA at 0.75× 2025 revenue, indicating low multiple
• Key Bruker staff in Germany and USA will join XRF

Pulse Analysis

XRF Scientific’s purchase of Bruker’s Combustion Gas Analysis unit marks a strategic pivot from its traditional mining‑focused instrumentation toward broader industrial applications. By adding CGA elemental analysers, XRF can address sectors such as petrochemicals, environmental monitoring, and food safety, where precise gas composition data drives compliance and process optimization. The acquisition also secures a ready‑made sales and support team, preserving customer relationships and accelerating market entry without the typical ramp‑up lag of a greenfield launch.

Financially, the deal is modest—$4 million cash plus a performance‑based earn‑out—yet it represents a 0.75‑times multiple on CGA’s 2025 revenue of $5.3 million, suggesting a bargain price relative to industry norms. XRF funds the purchase from its robust cash position, underpinned by a March 2026 quarter that delivered roughly $10.4 million USD in revenue and $2.4 million USD profit before tax, a double‑digit YoY growth. The earn‑out aligns incentives, ensuring Bruker’s legacy team remains focused on driving sales, while cross‑selling opportunities with XRF’s existing X‑ray fluorescence platforms could boost consumable margins.

The primary risk lies in the operational handover of manufacturing from Germany to Perth, scheduled for completion in Q3 2026. Such a relocation can strain supply chains, affect product quality, and delay the anticipated Q4 2026 revenue start. Investors will monitor integration milestones, ramp‑up speed, and early sales traction. If XRF navigates these challenges, the CGA addition could diversify earnings, improve cash flow stability, and position the company as a more resilient player in the global analytical instrumentation market.

Deal Summary

XRF Scientific (ASX:XRF) announced it will acquire Bruker AXS SE’s Combustion Gas Analysis (CGA) business for $4 million upfront, with an earn‑out of up to $1 million over three years. The deal includes the CGA product line, equipment and key staff, and is expected to close within the week, expanding XRF’s portfolio into non‑mining industrial markets. Manufacturing will shift to XRF’s Perth facility, with revenue anticipated from Q4 2026.